Sleep Aids (Pharmacies) - France | Statista Market Forecast

Revenue in the Sleep Aids market is projected to reach US$336.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.06%, resulting in a market volume of US$372.50m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$5.19 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in France is experiencing significant growth and development.

Customer preferences: Customers in France are increasingly seeking sleep aids to address their sleep-related issues. The modern lifestyle, characterized by high stress levels and busy schedules, has led to an increase in sleep disorders and insomnia among the population. As a result, there is a growing demand for sleep aids that can help individuals improve the quality and duration of their sleep.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in France is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of synthetic sleep aids and are opting for natural alternatives. This trend is driven by the growing interest in holistic health and wellness, as well as the preference for products with fewer chemicals and additives. Another trend in the market is the increasing availability and accessibility of sleep aids in pharmacies. Pharmacies in France are expanding their product offerings to cater to the growing demand for sleep aids. This includes a wider range of over-the-counter sleep aids, as well as prescription medications for more severe sleep disorders. The ease of access to sleep aids in pharmacies makes it convenient for customers to seek help for their sleep issues.

Local special circumstances: France has a well-developed healthcare system, which includes a strong network of pharmacies across the country. This infrastructure provides a favorable environment for the growth of the Sleep Aids (Pharmacies) market. Pharmacies in France are trusted sources of healthcare products and services, and customers feel confident in seeking advice and purchasing sleep aids from these establishments.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in France is also influenced by underlying macroeconomic factors. The increasing prevalence of sleep disorders and insomnia can be attributed to the modern lifestyle and the associated stress levels. Additionally, the aging population in France is also contributing to the growth of the market, as sleep disorders become more common with age. The economic stability and disposable income of the population further support the demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in France is experiencing growth and development due to customer preferences for natural sleep aids, the increasing availability of sleep aids in pharmacies, the well-developed healthcare system, and underlying macroeconomic factors such as the modern lifestyle and aging population. This market trend is expected to continue as more individuals seek solutions for their sleep-related issues.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.